TipRanks
Go Ultimate55% OFF

First Trust NYSE Arca Biotechnology UCITS ETF (DE:1FU6) Price & Chart

DE:1FU6 ETF Chart & Stats

€28.99
At close: 4:00 PM EDT
EUR 27EUR 28EUR 2929 Jul11 Aug25 Aug10 Sep30 Sep12 Oct
Day’s Range
EUR 28.99 - EUR 28.99
52-Week Range
EUR 19.80 - EUR 30.00
Previous Close
EUR 28.99
Volume
0
Average Volume (3M)
149
AUM
18.35M
NAV
32.98
Expense Ratio
0.63%
Holdings Count
31
Beta
0.60
Inception Date
May 27, 2020
Last Dividend Ex-Date
N/A
Dividend Yield
N/A
Shares Outstanding
550,002
Standard Deviation
N/A

ETF Overview

First Trust NYSE Arca Biotechnology UCITS ETF

The First Trust NYSE Arca Biotechnology UCITS ETF, trading under the ticker DE:1FU6, is a specialized investment vehicle designed for those seeking targeted exposure within the dynamic health care sector. This ETF zeroes in on the biotechnology niche, a frontier of medical innovation where groundbreaking developments shape the future of health care. By investing in this fund, investors gain access to a curated portfolio of companies at the forefront of biotech advancements, ranging from genetic sequencing to cutting-edge pharmaceuticals and beyond. This ETF is not only a gateway to potential high-growth opportunities but also a means to align one's investment strategy with the rapidly evolving landscape of biotechnology. Suitable for investors with a keen interest in health care innovations, the First Trust NYSE Arca Biotechnology UCITS ETF offers a strategic approach to capturing the potential upside of the biotech revolution while navigating the complexities of this specialized market.

DE:1FU6 ETF FAQ

What was DE:1FU6’s price range in the past 12 months?
DE:1FU6’s lowest price in the past 12 months was EUR 19.80 and its highest was EUR 30.00.
What is the AUM of DE:1FU6?
As of Oct 23, 2026, the AUM of DE:1FU6 is €18.35M.
Is DE:1FU6 overvalued?
Based on Wall Street analyst price targets for DE:1FU6’s holdings, DE:1FU6’s price is currently undervalued.
How many shares outstanding does DE:1FU6 have?
DE:1FU6 has 550,002 shares outstanding.